Extracellular Vesicles Released from Stem Cells as a New Therapeutic Strategy for Primary and Secondary Glomerulonephritis

Current treatment of primary and secondary glomerulopathies is hampered by many limits and a significant proportion of these disorders still evolves towards end-stage renal disease. A possible answer to this unmet challenge could be represented by therapies with stem cells, which include a variety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Quaglia, Marco, Merlotti, Guido, Fornara, Laura, Colombatto, Andrea, Cantaluppi, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142886/
https://www.ncbi.nlm.nih.gov/pubmed/35628570
http://dx.doi.org/10.3390/ijms23105760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142886/
https://www.ncbi.nlm.nih.gov/pubmed/35628570
http://dx.doi.org/10.3390/ijms23105760

Ejemplares similares